WPPAC 2021
Read the full Report (pdf)
IFPA 6th World Psoriasis & Psoriatic Arthritis Conference
30 June – 3 July 2021
Featured articles
CONTENTS
Online First
Patient Perceptions and Epidemiology
PsoBarrier EU: Large survey evaluating quality of care in Europe
Bridging the gap between patients and access to psoriasis specialists
Psoriasis and PsA in transgender adults on hormone therapy
Disease Progression
Psoriasis: New disease severity classification
Active PsA: Biomarkers distinguish radiographic progressors from non-progressors
Axial involvement is critical in psoriatic arthritis
COVID-19
Psoriasis registries yield important data about COVID-19
COVID-19 affects patients and care
Vaccination feasible in people with psoriatic disease
Low COVID-19 risk for patients with psoriasis on biologic treatment
Pathogenesis and the Gut-Skin Axis
Psoriasis: Disrupted gut-skin axis
Psoriasis associated with increased duodenum inflammation
Whole-exome sequencing to study the underlying pathogenesis of psoriasis
Treatment Guidelines
Pan-European guidelines for the treatment of psoriasis and comorbid conditions
Psoriatic arthritis: Guidelines and best practice
Cardiovascular Comorbidities
Patients with PsA have a higher cardiovascular risk
Potential role of inflammation in cardiovascular comorbidity
New Treatments
Psoriasis: New treatments and current pipeline
Rapid pustule and skin clearance with IL-36 receptor inhibitor spesolimab
